GPR37 and Parkinson disease: IPA has been demonstrated to act as a chemical chaperone, reducing endoplasmic reticulum (ER) stress in cells that overexpress Parkin-associated endothelin-like receptor (GPR37) and α-synuclein, thus modeling PD [42].